2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Sleep: new trials by email Literature Review of Sleep trials Research Report on Sleep
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) Project ViSi Mobile device, Sleep enhancement intervention - Sleep | Phase 2 / Phase 3 | Terminated | M.D. Anderson Cancer Center | 89 | 2023-03-01 | 2024-12-18 |
| Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder Suvorexant, Suvorexant Placebo - Opioid-use Disorder, Sleep | Phase 2 | Terminated | Wayne State University | 37 | 2021-02-01 | 2024-09-25 |
Chemically-Induced Disorders (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Substance-Related Disorders (1)
suvorexant (1)
M.D. Anderson Cancer Center (1) · Wayne State University (1)
United States (2)
Mark K Greenwald, PhD (1) · Vijaya Gottumukkala, MD (1)